flatreader
My Feed
Login
Sign Up
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, to step down as company seeks a turnaround - statnews.com
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, to step down as company seeks a turnaround
statnews.com
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
The New York Times
Novo Nordisk: CEO’s Surprise Departure Points to Challenging Obesity Market Dynamics
Morningstar
Novo Nordisk ousts CEO as Wegovy maker faces growing competition
CNBC
Novo Nordisk rode Ozempic’s success to becoming Europe’s top company. Now it’s faltering and its CEO is out.
MarketWatch